XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Equity-Based Compensation Expense

Equity-based compensation expense is classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(In thousands)

 

Research and development

 

$

16,383

 

 

$

9,017

 

 

$

40,736

 

 

$

18,643

 

General and administrative

 

 

8,832

 

 

 

6,393

 

 

 

26,038

 

 

 

13,805

 

Total

 

$

25,215

 

 

$

15,410

 

 

$

66,774

 

 

$

32,448

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s RSU activity for the nine months ended September 30, 2022:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair Value
per Share

 

Unvested restricted stock units as of December 31, 2021

 

 

453,026

 

 

$

71.03

 

Granted

 

 

1,648,664

 

 

 

72.48

 

Vested

 

 

(91,843

)

 

 

66.53

 

Cancelled

 

 

(82,093

)

 

 

76.55

 

Unvested restricted stock units as of September 30, 2022

 

 

1,927,754

 

 

$

72.25

 

Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted Weighted average assumptions used to apply this pricing model were as follows:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2022

 

2021

 

2022

 

2021

Risk-free interest rate

 

n/a

 

1.0%

 

1.9%

 

0.9%

Expected life of options

 

n/a

 

6.0 years

 

5.9 years

 

6.0 years

Expected volatility of underlying stock

 

n/a

 

75.2%

 

76.2%

 

72.7%

Expected dividend yield

 

n/a

 

0.0%

 

0.0%

 

0.0%

Summary of Stock Option Activity

The following is a summary of stock option activity for the nine months ended September 30, 2022:

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price per
Share

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding at December 31, 2021

 

 

6,305,156

 

 

$

43.57

 

 

 

 

 

 

 

Granted

 

 

391,910

 

 

 

86.08

 

 

 

 

 

 

 

Exercised

 

 

(852,913

)

 

 

16.40

 

 

 

 

 

 

 

Forfeited

 

 

(295,691

)

 

 

59.08

 

 

 

 

 

 

 

Outstanding at September 30, 2022

 

 

5,548,462

 

 

$

49.92

 

 

 

7.63

 

 

$

117,003

 

Exercisable at September 30, 2022

 

 

2,855,525

 

 

$

33.61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Employee Stock Purchase Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted

The fair value of the awards issued under the 2016 Plan to employees was estimated at the beginning of the offering period using a Black-Scholes option-pricing model with the following assumptions:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2022

 

2021

 

2022

 

2021

Risk-free interest rate

 

2.52%

 

0.05%

 

0.22%-2.52%

 

0.05%-0.09%

Expected term (in years)

 

0.5 years

 

0.5 years

 

0.5 years

 

0.5 years

Expected volatility of underlying stock

 

95.3%

 

109.2%

 

63.6%-95.3%

 

77.5%-109.2%

Expected dividend yield

 

0.0%

 

0.0%

 

0.0%

 

0.0%